Geode Capital Management, LLC Vbi Vaccines Inc Transaction History

Geode Capital Management, LLC

$1.21 Trillion
Q3 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$0.29 - $0.64 $1,827 - $4,033	6,303 Added 0.16%	3,896,669 $1.17 Million
Q4 2022 Feb 13, 2023	SELL	$0.38 - $22.5 $2,208 - $130,747	-5,811 Reduced 0.15%	3,890,366 $1.52 Million
Q3 2022 Nov 14, 2022	SELL	$0.73 - $23.4 $159,162 - $5.1 Million	-218,031 Reduced 5.3%	3,896,177 $2.75 Million
Q2 2022 Aug 12, 2022	BUY	$0.66 - $1.81 $121,857 - $334,183	184,632 Added 4.7%	4,114,208 $3.33 Million
Q1 2022 May 13, 2022	BUY	$1.27 - $2.47 $202,785 - $394,394	159,674 Added 4.24%	3,929,576 $6.52 Million
Q4 2021 Feb 11, 2022	SELL	$2.21 - $3.22 $278,848 - $406,286	-126,176 Reduced 3.24%	3,769,902 $8.82 Million
Q3 2021 Nov 12, 2021	BUY	$2.8 - $3.72 $668,908 - $888,693	238,896 Added 6.53%	3,896,078 $12.1 Million
Q2 2021 Aug 13, 2021	BUY	$2.61 - $4.17 $461,591 - $737,485	176,855 Added 5.08%	3,657,182 $12.3 Million
Q1 2021 May 12, 2021	BUY	$2.91 - $4.32 $1.5 Million - $2.23 Million	516,133 Added 17.41%	3,480,327 $10.8 Million
Q4 2020 Feb 12, 2021	BUY	$2.15 - $3.5 $298,727 - $486,300	138,943 Added 4.92%	2,964,194 $8.15 Million
Q3 2020 Nov 13, 2020	SELL	$2.77 - $6.17 $135,788 - $302,459	-49,021 Reduced 1.71%	2,825,251 $8.08 Million
Q2 2020 Aug 13, 2020	BUY	$0.87 - $3.13 $432,626 - $1.56 Million	497,272 Added 20.92%	2,874,272 $8.91 Million
Q1 2020 May 14, 2020	SELL	$0.73 - $1.91 $51,719 - $135,319	-70,848 Reduced 2.89%	2,377,000 $2.26 Million
Q4 2019 Feb 13, 2020	BUY	$0.48 - $1.38 $473,794 - $1.36 Million	987,072 Added 67.57%	2,447,848 $3.38 Million
Q3 2019 Nov 12, 2019	BUY	$0.47 - $1.05 $191,343 - $427,468	407,113 Added 38.64%	1,460,776 $688,000
Q2 2019 Aug 14, 2019	BUY	$0.65 - $2.12 $275,317 - $897,957	423,565 Added 67.22%	1,053,663 $1.23 Million
Q1 2019 May 14, 2019	BUY	$1.54 - $2.01 $228,244 - $297,904	148,211 Added 30.76%	630,098 $1.18 Million
Q4 2018 Feb 13, 2019	BUY	$1.22 - $2.41 $346,838 - $685,148	284,294 Added 143.88%	481,887 $771,000
Q3 2018 Nov 13, 2018	BUY	$1.75 - $2.93 $45,129 - $75,558	25,788 Added 15.01%	197,593 $478,000
Q2 2018 Aug 14, 2018	BUY	$2.75 - $3.85 $214,370 - $300,119	77,953 Added 83.06%	171,805 $472,000
Q1 2018 May 15, 2018	BUY	$3.5 - $4.47 $28,171 - $35,979	8,049 Added 9.38%	93,852 $328,000
Q4 2017 Feb 13, 2018	BUY	$3.29 - $5.03 $96,107 - $146,936	29,212 Added 51.62%	85,803 $366,000
Q3 2017 Nov 14, 2017	BUY	$3.15 - $4.01 $8,224 - $10,470	2,611 Added 4.84%	56,591 $217,000
Q2 2017 Aug 14, 2017	BUY	N/A	53,980	53,980 $234,000

Others Institutions Holding VBIV

# of Institutions

Shares Held

688K

Call Options Held

Put Options Held

Frontier Wealth Management LLC Kansas City, MO

602K
Shares

$12,036
0.01% of portfolio
ETF Managers Group, LLC Summit, NJ

85.7K
Shares

$1,714
0.0% of portfolio

View Full List

About VBI Vaccines Inc

Ticker VBIV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 258,256,992
Market Cap $5.17M
Description
VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The...

More about VBIV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account